Get started
Mind Medicine (MindMed), Inc.Mind Medicine (MindMed), Inc.Mind Medicine (MindMed), Inc.

Mind Medicine (MindMed), Inc.

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsForecastsSeasonalsETFs

Live chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪860.01 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.16 EUR
Net income (FY)
‪−104.98 M‬ EUR
Revenue (FY)
0.00 EUR
Shares float
‪72.58 M‬
Beta (1Y)
2.02

Employees


Employees (FY)
74
Change (1Y)
+17 +29.82%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About Mind Medicine (MindMed) Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Robert Barrow
Website
mindmed.co
Headquarters
New York
Founded
2010
ISIN
CA60255C8850
FIGI
BBG00FD7MXV5
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Check out other big names from the same industry as MMQ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs


IWM
iShares Russell 2000 ETF
Weight
0.03%
Market value
‪23.80 M‬
USD
IWN
iShares Russell 2000 Value ETF
Weight
0.05%
Market value
‪5.98 M‬
USD
VTWO
Vanguard Russell 2000 ETF
Weight
0.03%
Market value
‪4.23 M‬
USD
XPH
SPDR S&P Pharmaceuticals ETF
Weight
1.94%
Market value
‪3.52 M‬
USD
IWO
iShares Russell 2000 Growth ETF
Weight
0.02%
Market value
‪2.78 M‬
USD
IWC
iShares Micro-Cap ETF
Weight
0.22%
Market value
‪2.31 M‬
USD
IHE
iShares U.S. Pharmaceuticals ETF
Weight
0.36%
Market value
‪2.15 M‬
USD
VHT
Vanguard Health Care ETF
Weight
0.01%
Market value
‪2.13 M‬
USD
PSIL
AdvisorShares Psychedelics ETF
Weight
8.35%
Market value
‪1.78 M‬
USD
R2US
SPDR Russell 2000 U.S. Small Cap UCITS ETF
Weight
0.04%
Market value
‪1.69 M‬
USD
ESML
iShares ESG Aware MSCI USA Small-Cap ETF
Weight
0.06%
Market value
‪1.30 M‬
USD

Explore more ETFs 

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Mind Medicine (MindMed), Inc. stocks are traded under the ticker MMQ.
We've gathered analysts' opinions on Mind Medicine (MindMed), Inc. future price: according to them, MMQ price has a max estimate of 47.24 EUR and a min estimate of 13.74 EUR. Watch MMQ chart and read a more detailed Mind Medicine (MindMed), Inc. stock forecast: see what analysts think of Mind Medicine (MindMed), Inc. and suggest that you do with its stocks.
MMQ reached its all-time high on Apr 27, 2021 with the price of 75.00 EUR, and its all-time low was 1.96 EUR and was reached on Dec 29, 2022. View more price dynamics on MMQ chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Mind Medicine (MindMed), Inc. financials in yearly and quarterly reports right on TradingView.
Mind Medicine (MindMed), Inc. is going to release the next earnings report on Nov 12, 2025. Keep track of upcoming events with our Earnings Calendar.
MMQ earnings for the last quarter are −0.42 EUR per share, whereas the estimation was −0.32 EUR resulting in a −31.58% surprise. The estimated earnings for the next quarter are −0.43 EUR per share. See more details about Mind Medicine (MindMed), Inc. earnings.
Mind Medicine (MindMed), Inc. revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
MMQ net income for the last quarter is ‪−36.29 M‬ EUR, while the quarter before that showed ‪−21.58 M‬ EUR of net income which accounts for −68.13% change. Track more Mind Medicine (MindMed), Inc. financial stats to get the full picture.
No, MMQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 21, 2025, the company has 74 employees. See our rating of the largest employees — is Mind Medicine (MindMed), Inc. on this list?
Like other stocks, MMQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mind Medicine (MindMed), Inc. stock right from TradingView charts — choose your broker and connect to your account.